Gene · 2217
Papers4,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Management of autoimmune hemolytic anemia. | Hematology Am Soc Hematol Educ Program | 2025 | 41347987 | PubTator, text mining | PubMed |
| Engineered neutrophil engagers overcome IgA limitations and reprogram resting neutrophils for cancer immunotherapy. | J Biol Eng | 2025 | 41345694 | PubTator, text mining | PubMed |
| Selective decoupling of IgG1 binding to viral Fc receptors restores antibody-mediated NK cell activation against HCMV. | Cell Rep | 2025 | 41343276 | PubTator, text mining | PubMed |
| What is in the Neuromuscular Junction Literature? | J Clin Neuromuscul Dis | 2025 | 41331966 | PubTator, text mining | PubMed |
| Dysregulated plasmacytoid dendritic cells in primary Sjögren's syndrome: normal functionality but decreased quantities. | Clin Exp Rheumatol | 2025 | 41328603 | PubTator, text mining | PubMed |
| Maternal allergy and neonatal RSV infection synergize via FcR-mediated allergen uptake to promote the development of asthma in early life. | Sci Immunol | 2025 | 41313755 | PubTator, text mining | PubMed |
| On the coupling between a basic FcRn mechanism and target-mediated disposition of antibodies. | J Pharmacokinet Pharmacodyn | 2025 | 41307781 | PubTator, text mining | PubMed |
| Changes in the Interaction Properties of Antibodies with Fc Receptors upon Binding to Target Antigens. | Biosensors (Basel) | 2025 | 41294769 | PubTator, text mining | PubMed |
| Evaluating inebilizumab in the treatment of generalized myasthenia gravis. | Immunotherapy | 2025 | 41290420 | PubTator, text mining | PubMed |
| Intravenous Efgartigimod or Intravenous Immunoglobulin in Guillain-Barre Syndrome: An Observational Multicenter Study. | J Peripher Nerv Syst | 2025 | 41287201 | PubTator, text mining | PubMed |
| Neural Immunoglobulins Shape Brain Circuits. | Eur J Neurosci | 2025 | 41285112 | PubTator, text mining | PubMed |
| Case Report: KLHL11 encephalitis in a female patient with dual primary malignancies of breast and lung cancer: response to FcRn inhibitor therapy. | Front Immunol | 2025 | 41280942 | PubTator, text mining | PubMed |
| Photostability of Topoisomerase I Inhibitor Conjugated IgG1 Antibody-Drug Conjugates: Characterization Study and Degradation Mechanism Analysis. | Bioconjug Chem | 2025 | 41273300 | PubTator, text mining | PubMed |
| Towards new approach methodologies for biological therapeutics: a novel model-informed metric to assess immunogenicity risk. | Front Immunol | 2025 | 41256850 | PubTator, text mining | PubMed |
| Editorial: Autoimmunity: novel insights and future perspectives. | Front Immunol | 2025 | 41246308 | PubTator, text mining | PubMed |
| Predicting the Pharmacokinetics of T-Cell Engagers as a Function of Target-Mediated Drug Disposition. | Clin Transl Sci | 2025 | 41208206 | PubTator, text mining | PubMed |
| Double-filtration plasmapheresis as an adjunct to therapy for severe early-onset maternal erythrocyte alloimmunization. | BMC Pregnancy Childbirth | 2025 | 41204135 | PubTator, text mining | PubMed |
| Genetic signatures predict social-cognitive trajectories in ultra-high-risk psychosis: A 24-month longitudinal study. | Asian J Psychiatr | 2025 | 41202776 | PubTator, text mining | PubMed |
| From discovery to the clinic: structural insights, engineering options, clinical, and 'next wave' applications of camelid-derived single-domain antibodies. | MAbs | 2025 | 41193399 | PubTator, text mining | PubMed |
| Structure of the human astrovirus capsid spike in complex with the neonatal Fc receptor. | Nat Commun | 2025 | 41184319 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2217/papers?page=14